SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001144204-19-029805
Filing Date
2019-06-05
Accepted
2019-06-05 07:00:28
Documents
3
Period of Report
2019-06-05
Items
Item 2.02: Results of Operations and Financial Condition
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tv523119_8k.htm 8-K 19165
2 EXHIBIT 99.1 tv523119_ex99-1.htm EX-99.1 30611
3 GRAPHIC image_001.jpg GRAPHIC 5964
  Complete submission text file 0001144204-19-029805.txt   59377
Mailing Address 4955 DIRECTORS PLACE SAN DIEGO CA 92121
Business Address 4955 DIRECTORS PLACE SAN DIEGO CA 92121 858-203-4100
Sorrento Therapeutics, Inc. (Filer) CIK: 0000850261 (see all company filings)

IRS No.: 330344842 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36150 | Film No.: 19878516
SIC: 8731 Services-Commercial Physical & Biological Research